Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1997-2-11
|
pubmed:abstractText |
Left ventricular hypertrophy (LVH) is one of the physiopathological effects of hypertension and one of the main risk factors for sudden death, myocardial infarction and congestive heart failure. Drugs to treat hypertension must not only reduce blood pressure, but also modify the facts which lead to ventricular hypertrophy. This study has been designed to assess the effect of amlodipine, a calcium-antagonist, on LVH in hypertensive patients.
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0212-7199
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
531-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9019211-Amlodipine,
pubmed-meshheading:9019211-Antihypertensive Agents,
pubmed-meshheading:9019211-Echocardiography,
pubmed-meshheading:9019211-Female,
pubmed-meshheading:9019211-Humans,
pubmed-meshheading:9019211-Hypertension,
pubmed-meshheading:9019211-Hypertrophy, Left Ventricular,
pubmed-meshheading:9019211-Male,
pubmed-meshheading:9019211-Middle Aged,
pubmed-meshheading:9019211-Single-Blind Method
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Effect of the treatment with amlodipine on left ventricular hypertrophy in hypertensive patients].
|
pubmed:affiliation |
Departamento de Medicina, Unidad de Hipertensión Arterial y Factores de Riesgo, Hospital Universitario Virgen Macarena, Sevilla.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|